At the same time, in humans FAM13C was shown to be associated with endometrial mixed adenocarcinoma [55] as well as being used as a marker for prostate cancer [75] or as a rectal adenocarcinoma survival predictor [76]. This evidence concerns the gene FAM13C and endometrial mixed adenocarcinoma.